Bray F, Ren J S, Masuyer E, et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008[J]. Int J Cancer, 2013, 132(5): 1133-1145. [2]Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359-E386. [3]Ahmed H G, Abdul-Gader-Suliman R S, Abd-El-Aziz M S, et al. Immunohistochemical expression of cytokeratins and epithelial membrane protein 2 in nasopharyngeal carcinoma and its potential implications[J]. Asian Pac J Cancer Prev, 2015, 16(2): 653-656. [4]Chen Y H, Wu L C, Wu W R, et al. Loss of epithelial membrane protein-2 expression confers an independent prognosticator in nasopharyngeal carcinoma: a cohort study[J]. BMJ Open, 2012, 2(2): e000900. [5]Habeeb O, Goodglick L, Soslow R A, et al. Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development[J]. Cancer, 2010, 116(20): 4718-4726. [6]Wang Y W, Li W M, Wu W J, et al. Epithelial membrane protein 2 is a prognostic indictor for patients with urothelial carcinoma of the upper urinary tract[J]. Am J Pathol, 2013, 183(3): 709-719. [7]Fu M, Maresh E L, Soslow R A, et al. Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer[J]. Clin Cancer Res, 2010, 16(15): 3954-3963. [8]Fu M, Rao R, Sudhakar D, et al. Epithelial membrane protein-2 promotes endometrial tumor formation through activation of FAK and Src[J]. PLoS One, 2011, 6(5): e19945. [9]Qin Y, Fu M, Takahashi M, et al. Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma[J]. J Biol Chem, 2014, 289(20): 13974-13985.
[2]
刘晓丽,马礼鸿,王全义,等.XIAP、c-jun在肺癌组织中的表达及其意义[J].第三军医大学学报,2012,34(23):2408. Liu Xiaoli,Ma Lihong,Wang Quanyi,et al.Expression and clinical significance of XIAP and c-jun in human lung cancer tissues[J].J Third Mil Med Univ,2012,34(23):2408. [2]蒋平,关伟,戴楠,等.DNA损伤修复基因以及TS、β-tubulinⅢ在骨肉瘤中的表达及其与临床病理的关系[J].第三军医大学学报,2013,35(01):61. Jiang Ping,Guan Wei,Dai Nan,et al.Expression of DNA damage repair genes, thymidylate synthase and β-tubulin Ⅲ in human osteosarcoma tissues and its relationship with clinical pathology of osteosarcoma[J].J Third Mil Med Univ,2013,35(23):61. [3]杨兆瑞,吴晴,陈嘉薇,等.HIF-1α、JNK1、P-gp、MRP1和LRP蛋白在胃癌中的表达与临床病理及预后的关系[J].第三军医大学学报,2007,29(18):1755. YANG Zhao-rui,WU Qing,CHEN Jia-wei,et al.Expressions, clinicopathological features and prognostic significance of HIF-1α, JNK1, P-gp, MRP1 and LRP proteins in human gastric carcinoma[J].J Third Mil Med Univ,2007,29(23):1755. [4]吴晋蓉,曾发贵,王清良,等.定量分析人脑星形细胞肿瘤组织芯片中血管生成与肿瘤微血管结构[J].第三军医大学学报,2006,28(10):1090. [5]王清良,卞修武,章容,等.人脑星形细胞肿瘤微血管组织芯片的构建[J].第三军医大学学报,2006,28(09):886. [6]唐春兰,杨和平,卞修武,等.应用组织芯片技术研究非小细胞肺癌中MMP-2、MMP-9的表达及临床病理意义[J].第三军医大学学报,2009,31(06):518. TANG Chun-lan,YANG He-ping,BIAN Xiu-wu,et al.Clinicopathological significance of MMP-2 and MMP-9 expressions in non-small cell lung cancer: a tissue microarray study[J].J Third Mil Med Univ,2009,31(23):518. [7]张真真,张声,余英豪,等.Claudin-3在胃腺癌的表达及预后意义[J].第三军医大学学报,2011,33(12):1250. Zhang Zhenzhen,Zhang Sheng,Yu Yinghao,et al.Expression of Claudin-3 in gastric adenocarcinoma tissue and its relation with prognosis[J].J Third Mil Med Univ,2011,33(23):1250. [8]邓佳,谢赣丰,舒秋霞,等.脂肪酰胺水解酶在结直肠癌中的表达及临床意义[J].第三军医大学学报,2012,34(09):899. Deng Jia,Xie Ganfeng,Shu Qiuxia,et al.Expression of fatty acid amide hydrolase in colorectal cancer and its clinical significance[J].J Third Mil Med Univ,2012,34(23):899. [9]肖瑜,龙驰,张明慧,等.Beclin-1在非小细胞肺癌中的表达与意义[J].第三军医大学学报,2013,35(12):1271. Xiao Yu,Long Chi,Zhang Minghui,et al.Expression of Beclin-1 in non-small cell lung cancer and its clinical significance[J].J Third Mil Med Univ,2013,35(23):1271. [10]周荣斌,周杰,吴双,等.2型脯氨酸羟化酶在结直肠癌中的表达及临床意义[J].第三军医大学学报,2014,36(04):336. Zhou Rongbin,Zhou Jie,Wu Shuang,et al.Expression of proline hydroxylase domain 2 in colorectal cancer and its clinical significance[J].J Third Mil Med Univ,2014,36(23):336.
